Skip to content

Study of Placental Function in Healthy and Pathological Pregnancies

Study of Placental Function in Healthy and Pathological Pregnancies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02321007
Enrollment
1250
Registered
2014-12-19
Start date
2014-09-01
Completion date
2031-09-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Brief summary

The purpose of this study is to establish a tissue and data repository consisting of samples of human placentas, umbilical cord blood, and maternal blood, collected at the time of delivery. Specimens will be used in cellular, molecular, and functional studies to learn more about changes in placental structure and function, which can result in serious pregnancy complications and determine life-long health by programming the fetus for future metabolic and cardiovascular disease.

Interventions

None listed

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy women delivering at term * Women with pregnancy complications such as: * pre-term birth, * intrauterine growth restriction, * diabetes, and * obesity.

Exclusion criteria

* Women: * under stress, * experiencing pain of labor. * Pregnancies complicated by other pathologies.

Design outcomes

Primary

MeasureTime frameDescription
Collecting, processing, and archiving human specimens from 1250 subjectsSpecimens will be stored for 50 years in repositoryHuman placental tissue, umbilical cord blood, and maternal blood samples will be collected from pregnant women at the time of their delivery. The samples will be used to enhance understanding of the role of the placenta in the development of pregnancy complications and in programming of adult disease.

Countries

United States

Contacts

CONTACTAnita Kramer
anita.kramer@ucdenver.edu303-724-1653
PRINCIPAL_INVESTIGATORThomas Jansson, MD, PhD

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026